Lv31
350 积分 2022-09-28 加入
Multi‐target Drugs to Treat Metabolic Diseases
4小时前
待确认
An explainable deep learning platform for molecular discovery
21天前
已完结
Deep profiling of gene expression across 18 human cancers
3个月前
已完结
Interpretable identification of cancer genes across biological networks via transformer-powered graph representation learning
4个月前
已完结
Robustness and resilience of complex networks
9个月前
已完结
The role of the circadian clock in the development, progression, and treatment of non‐alcoholic fatty liver disease
9个月前
已完结
Integration of Metabolomics, Lipidomics, and Proteomics Reveals the Metabolic Characterization of Nonalcoholic Steatohepatitis
10个月前
已完结
Mitochondrial pyruvate carrier 1 regulates fatty acid synthase lactylation and mediates treatment of nonalcoholic fatty liver disease
10个月前
已完结
Matrisome gene-based subclassification of patients with liver fibrosis identifies clinical and molecular heterogeneities
11个月前
已完结
NASH drug treatment development: challenges and lessons
11个月前
已完结
皖公网安备34019202002308
